Workflow GuideEndocrinology

Endocrine Patient Risk Stratification & Chronic Care Workflow

Optimize Endocrinology workflows with AI-driven risk stratification for diabetes and metabolic care to improve A1C outcomes and APCM revenue.

Effective risk stratification is the backbone of successful Endocrinology practices, especially with the rise of Advanced Primary Care Management (APCM). By categorizing patients based on A1C levels, insulin dependency, and metabolic comorbidities, practices can prioritize high-risk outreach. AI-powered call handling streamlines this by automating data collection and triage, ensuring that thyro...

The Challenge

Manual risk stratification in endocrinology is often reactive, occurring only during office visits. This leads to missed APCM billing opportunities, delayed insulin adjustments for uncontrolled diabetics, and overlooked TSH monitoring, resulting in poor clinical outcomes and staff burnout.

Step-by-Step Workflow

1

Identify APCM Eligibility and Comorbidities

Audit your patient panel to identify those with two or more chronic conditions, such as Type 2 Diabetes combined with hypertension or obesity. Use AI to scan EHR records and flag patients who meet the CMS criteria for Advanced Primary Care Management services.

Best Practices
  • Focus on the 'Diabetes + 1' model for maximum APCM impact
  • Ensure ICD-10 codes for metabolic syndrome are current
Common Pitfalls
  • Overlooking thyroid patients with secondary hypertension
  • Failing to document the 20 minutes of monthly non-face-to-face care
2

Automated Glycemic Control Screening

Deploy AI voice agents to call patients with A1C levels above 8.0%. The AI collects current CGM data trends or finger-stick logs, identifies frequency of hypoglycemic episodes, and updates the patient record before the provider review.

Best Practices
  • Set the AI to trigger calls 48 hours before a scheduled titration review
  • Use natural language processing to capture patient-reported barriers to insulin adherence
Common Pitfalls
  • Relying solely on in-office A1C tests which may be outdated
  • Ignoring the social determinants that lead to poor glycemic control
3

Stratify by Medication Complexity

Divide the panel into risk tiers: Tier 1 for insulin-pump and multi-dose injection users, Tier 2 for oral-only diabetics, and Tier 3 for stable thyroid or adrenal patients. High-tier patients receive more frequent automated touchpoints.

Best Practices
  • Prioritize patients on U-500 insulin for weekly AI check-ins
  • Automate TSH monitoring reminders for Tier 3 patients every 6 months
Common Pitfalls
  • Treating all Type 2 patients as having the same risk profile
  • Under-monitoring patients during a medication switch (e.g., GLP-1 to SGLT2)
4

Deploy Titration Outreach Workflows

For patients in the high-risk tier, use AI to facilitate titration schedules. The system reaches out to confirm fasting glucose levels and, based on provider-set parameters, schedules a brief telehealth follow-up or confirms the next dose increase.

Best Practices
  • Integrate AI with your patient portal for seamless dose logging
  • Use automated SMS backups if the patient doesn't answer the risk-stratification call
Common Pitfalls
  • Allowing more than 30 days to pass without a titration check for new insulin starts
  • Manual phone tag which delays dosage adjustments
5

Continuous Metabolic Monitoring & Documentation

Ensure all automated interactions are transcribed and coded for APCM documentation. The AI should flag any red-flag responses—such as severe hypoglycemia or sudden weight gain—directly to the endocrine nurse or physician for immediate action.

Best Practices
  • Sync AI call summaries directly into the EHR progress notes
  • Use the 'time-on-call' as a component of billable chronic care minutes
Common Pitfalls
  • Failing to capture the patient's verbal consent for APCM enrollment
  • Losing data in silos between the call center and the clinical team
6

Quarterly Outcome Re-evaluation

Review the stratified tiers every 90 days. Move patients between tiers based on their updated A1C, weight loss progress, or TSH stability. This ensures clinical resources are always directed toward the most unstable metabolic patients.

Best Practices
  • Celebrate 'graduations' to lower-risk tiers to boost patient morale
  • Analyze which risk factors most frequently lead to ER visits in your panel
Common Pitfalls
  • Keeping stable patients in high-intensity monitoring tiers indefinitely
  • Neglecting the impact of seasonal changes on diabetic activity levels

Expected Outcomes

1

Increased APCM enrollment rates for high-risk diabetic patients

2

Significant reduction in average A1C levels through proactive titration

3

Improved staff efficiency by automating routine TSH and glucose data collection

4

Enhanced patient compliance with CGM and insulin therapy protocols

5

Higher practice revenue through optimized and documented chronic care billing

Frequently Asked Questions

The AI analyzes real-time data from patient calls and integrated devices, flagging those with frequent hypoglycemic events, high glycemic variability, or missed medication doses for immediate provider intervention.

Yes. Every AI-driven interaction is automatically timestamped, summarized, and logged, providing the necessary documentation for the 20+ minutes of monthly care required for APCM and CCM billing.

No. The AI handles the repetitive data gathering and routine monitoring, allowing CDCES staff to focus their expertise on complex education, lifestyle counseling, and advanced pump management.

The AI acts as a data bridge; it collects the necessary glucose readings and symptoms, then presents them to the provider or follows a strict, pre-approved titration algorithm set by the endocrinologist.

Ready to transform your endocrinology practice?

See how Tile Healthcare's AI call center can handle scheduling, triage, and patient communication for your practice.

Schedule a Demo
Endocrine Patient Risk Stratification & Chronic Care Workflow | Tile Health